A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer

被引：0
|
作者：
Fried, G
Zidan, J
Epelbaum, R
Keren-Rosenberg, S
Basher, W
Steckelman, I
Kogan, F
Haim, N
机构：
[1] Poriya Govt Hosp, Tiberias, Israel
[2] Sieff Hosp, Safed, Israel
[3] Rambam Med Ctr, Haifa, Israel
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80207-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [21] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Jesberger, J
    Hartman, P
    Dumadag, L
    Chen, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S106
  • [22] Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer
    Conti, F.
    Corsetti, S.
    Viola, G.
    Sperduti, I.
    Carpano, S.
    Pizzuti, L.
    Foggi, P.
    Perri, P.
    Anza, M.
    Toglia, G.
    Lopez, M.
    [J]. ONCOLOGY, 2009, 77 : 139 - 140
  • [23] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [24] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [25] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [26] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [27] Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: A phase II trial of the NSABP foundation research group
    Hamm, John T.
    Wilson, John W.
    Rastogi, Priya
    Lembersky, Barry C.
    Tseng, George C.
    Song, Young K.
    Kim, Wanseop
    Robidoux, Andre
    Raymond, Jane M.
    Kardinal, Carl G.
    Shalaby, Ibrahim A.
    Ansari, Rafat
    Paik, Soonmyung
    Geyer, Charles E.
    Wolmark, Norman
    [J]. CLINICAL BREAST CANCER, 2008, 8 (03) : 257 - 263
  • [28] The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer
    Costa, SD
    von Minckwitz, G
    Raab, G
    Blohmer, JU
    Dresel, V
    Eidtmann, H
    Hilfrich, J
    Jackisch, C
    Merkle, E
    Gademann, G
    Kaufmann, M
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (03) : 24 - 31
  • [29] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Allan T. van Oosterom
    Véronique Diéras
    Michele Tubiana-Hulin
    R. Charles Coombes
    Thomas Hatschek
    Michael Murawsky
    May Klink-Alakl
    Marcus Hudec
    Christian Dittrich
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 125 - 135
  • [30] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Baur, Martina
    van Oosterom, Allan T.
    Dieras, Veronique
    Tubiana-Hulin, Michele
    Coombes, R. Charles
    Hatschek, Thomas
    Murawsky, Michael
    Klink-Alakl, May
    Hudec, Marcus
    Dittrich, Christian
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 125 - 135
12345